指南与共识产科麻醉区域麻醉与超声

产科麻醉与围产期学会关于接受血栓预防或较高剂量抗凝治疗的孕妇及产后妇女麻醉管理的共识声明

The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants.
指南 / 共识 · Anesth Analg · 2018-01-01

静脉血栓栓塞是美国孕产妇死亡的主要原因,血栓预防可降低相关死亡,但会影晌椎管内镇痛与麻醉的时机选择。产科麻醉与围产期学会、美国区域麻醉学会及血液学专家合作制定本共识,整合抗凝药在产科人群的药代动力学与药效学数据,提供产前、产时及产后接受血栓预防或较高剂量抗凝治疗孕妇的识别、准备和管理实践指南,并强调多学科沟通与共享决策。

要点

  • 血栓预防扩大使用影响椎管内麻醉时机,需权衡椎管内操作风险与全麻困难气道及延迟麻醉的母婴风险。
  • 共识整合抗凝药在产科人群的药代动力学与药效学,提供循证依据和决策辅助工具。
  • 建议通过多学科沟通和共享决策,个体化评估接受抗凝治疗孕妇的椎管内麻醉风险获益。

核心结论

  • 本共识为接受血栓预防或较高剂量抗凝治疗的孕妇及产后妇女提供椎管内操作管理的实践指南,强调多学科沟通和共享决策。

研究设计与样本

  • 由产科麻醉与围产期学会、美国区域麻醉学会及血液学专家合作制定的共识声明,基于药代动力学与脊髓硬膜外血肿数据。

主要发现

  • 现有麻醉学会建议未权衡椎管内操作风险与全麻困难气道风险或避免/延迟椎管内麻醉的母婴伤害。
  • 现有指南未整合抗凝药在产科人群的药代动力学与药效学。

临床怎么用

  • 应识别、准备和管理产前、产时及产后接受血栓预防或较高剂量抗凝治疗的孕妇。
  • 利用多学科沟通、循证药代动力学与脊髓硬膜外血肿数据及决策辅助工具进行风险获益讨论和共享决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism is recognized as a leading cause of maternal death in the United States. Thromboprophylaxis has been highlighted as a key preventive measure to reduce venous thromboembolism-related maternal deaths. However, the expanded use of thromboprophylaxis in obstetrics will have a major impact on the use and timing of neuraxial analgesia and anesthesia for women undergoing vaginal or cesarean delivery and other obstetric surgeries. Experts from the Society of Obstetric Anesthesia and Perinatology, the American Society of Regional Anesthesia, and hematology have collaborated to develop this comprehensive, pregnancy-specific consensus statement on neuraxial procedures in obstetric patients receiving thromboprophylaxis or higher dose anticoagulants. To date, none of the existing anesthesia societies' recommendations have weighed the potential risks of neuraxial procedures in the presence of thromboprophylaxis, with the competing risks of general anesthesia with a potentially difficult airway, or maternal or fetal harm from avoidance or delayed neuraxial anesthesia. Furthermore, existing guidelines have not integrated the pharmacokinetics and pharmacodynamics of anticoagulants in the obstetric population. The goal of this consensus statement is to provide a practical guide of how to appropriately identify, prepare, and manage pregnant women receiving thromboprophylaxis or higher dose anticoagulants during the ante-, intra-, and postpartum periods. The tactics to facilitate multidisciplinary communication, evidence-based pharmacokinetic and spinal epidural hematoma data, and Decision Aids should help inform risk-benefit discussions with patients and facilitate shared decision making.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Leffert L, Butwick A, Carvalho B, et al. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants. Anesth Analg. 2018. PMID: 29099429. doi:10.1213/ANE.0000000000002530

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。